Family Medicine · Bellflower, CA
NPI
1255402152
Since 2006
Specialty
Family Medicine
Code 207Q00000X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
9400 Rosecrans Ave
Bellflower, CA, 90706
Phone (562) 461-3000
Groups this clinician bills Medicare through
Medicare paid, 2024
$1,628
24 services
Medicare patients, 2024
14
Average age 68
Drug cost, 2024
$374K
6,187 prescriptions
Company payments
-
None reported
Medicare prescription drug claims, 2024
In 2024, the drug Grigor Matentsian prescribed most often to Medicare patients was Atorvastatin Calcium, with 727 prescriptions and refills. In total Grigor Matentsian wrote 6,187 Medicare prescriptions that cost $374K.
| Drug |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2021-11-22.
| Claims |
|---|
| 30-day fills |
|---|
| Patients |
|---|
| Cost |
|---|
| Atorvastatin Calcium Generic | 727 | 2,413 | 308 | $8,615 |
| Losartan Potassium Generic | 473 | 1,564 | 183 | $5,513 |
| Metformin Hcl Generic | 316 | 1,028 | 127 | $3,701 |
| Amlodipine Besylate Generic | 295 | 980 | 125 | $3,601 |
| Tamsulosin Hcl Generic | 193 | 623 | 92 | $3,602 |
| Omeprazole Generic | 176 | 391 | 90 | $1,713 |
| Glipizide Generic | 170 | 559 | 77 | $2,314 |
| Lisinopril Generic | 166 | 553 | 66 | $1,988 |
| Rosuvastatin Calcium Generic | 155 | 507 | 61 | $1,790 |
| Atenolol Generic | 152 | 507 | 55 | $1,897 |
| Hydrochlorothiazide Generic | 151 | 503 | 64 | $1,739 |
| Nano 2nd Gen Pen Needle Pen Needle, Diabetic | 149 | 331 | 75 | $3,094 |
| Levothyroxine Sodium Generic | 124 | 398 | 48 | $2,343 |
| Jardiance Empagliflozin | 118 | 372 | 48 | $61K |
| Trazodone Hcl Generic | 96 | 297 | 49 | $1,179 |
Brand drugs: 756 claims; generic drugs: 5,191 claims; opioid claims: 121.
Money and other things of value reported by the companies
No payments from drug or medical device companies to Grigor Matentsian were reported in the years we have.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.